DENTSPLY SIRONA (NASDAQ:XRAY) Posts Quarterly Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY) issued its earnings results on Thursday. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08), Zacks reports. The firm had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.50 earnings per share. DENTSPLY SIRONA updated its FY 2025 guidance to 1.600-1.600 EPS.

DENTSPLY SIRONA Trading Down 12.7%

XRAY stock traded down $1.60 during trading on Thursday, hitting $11.02. 10,225,032 shares of the company traded hands, compared to its average volume of 3,052,153. The firm has a market capitalization of $2.20 billion, a PE ratio of -2.32, a P/E/G ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a 1 year low of $10.69 and a 1 year high of $20.59. The company has a 50-day moving average of $13.11 and a 200-day moving average of $14.51. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of XRAY. AQR Capital Management LLC lifted its holdings in DENTSPLY SIRONA by 109.8% in the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares during the period. Goldman Sachs Group Inc. raised its holdings in DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Qube Research & Technologies Ltd raised its holdings in DENTSPLY SIRONA by 28.7% in the second quarter. Qube Research & Technologies Ltd now owns 2,044,651 shares of the medical instruments supplier’s stock worth $32,469,000 after purchasing an additional 456,324 shares in the last quarter. Ieq Capital LLC raised its holdings in DENTSPLY SIRONA by 158.8% in the second quarter. Ieq Capital LLC now owns 632,520 shares of the medical instruments supplier’s stock worth $10,044,000 after purchasing an additional 388,078 shares in the last quarter. Finally, State Street Corp raised its holdings in DENTSPLY SIRONA by 5.5% in the second quarter. State Street Corp now owns 7,099,906 shares of the medical instruments supplier’s stock worth $113,868,000 after purchasing an additional 369,876 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on XRAY. UBS Group decreased their price objective on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research note on Tuesday, October 28th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Barrington Research reiterated an “outperform” rating and issued a $18.00 price objective on shares of DENTSPLY SIRONA in a report on Wednesday, October 29th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Finally, Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $17.55.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.